STOCK TITAN

Owlet Inc - OWLT STOCK NEWS

Welcome to our dedicated page for Owlet news (Ticker: OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet stock.

Owlet Inc (OWLT) delivers innovative digital parenting solutions through smart baby monitors and health-tracking wearables. This news hub provides investors and caregivers with essential updates on the company’s advancements in infant care technology.

Access real-time information on product launches, financial results, and strategic partnerships directly from official sources. Our curated collection includes press releases, regulatory filings, and market developments relevant to Owlet’s IoT-enabled ecosystem.

Key updates cover earnings announcements, FDA clearances for medical devices, retail expansions, and sleep solution program enhancements. Stay informed about innovations in wearable vitals monitoring and cloud-based parenting platforms that define Owlet’s market position.

Bookmark this page for streamlined access to verified OWLT updates. Combine ongoing monitoring with historical context to track the company’s progress in transforming infant care through connected devices.

Rhea-AI Summary

Owlet, Inc. announces the EU medical device certification of Dream Sock, a smart infant monitoring product. This certification allows Owlet to expand its product portfolio in European markets and provide caregivers with innovative technology for home-based baby monitoring. The product offers clinically-proven accuracy and real-time data delivery through a mobile app and Base Station. Dream Sock is set to launch in Germany, France, and the UK this spring, with plans for further European expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.97%
Tags
none
-
Rhea-AI Summary

Owlet, Inc. (NYSE: OWLT), a leader in smart infant monitoring, will be participating in two upcoming investor conferences: the Emerging Growth Virtual Conference on May 8, 2024, and the Sidoti May Micro Cap Virtual Conference on May 8-9, 2024. The Company's Co-Founder and CEO, Kurt Workman, along with CFO Kate Scolnick, will present at both events.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
conferences
-
Rhea-AI Summary

Owlet, Inc. will announce its first quarter 2024 financial results on May 6, 2024. The company's executives will host a conference call to discuss the results and provide a business update.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
conferences earnings
Rhea-AI Summary
Wheel partners with Owlet to enhance virtual health services by providing timely prescriptions for BabySat, a smart infant monitoring device, empowering caregivers with in-home monitoring capabilities. Owlet's virtual care offering integrated with Wheel's platform allows for easy prescription access and insurance reimbursement, expanding access to critical care for infants transitioning home from the NICU.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) partners with Wheel to launch virtual telehealth services platform, revolutionizing infant care with digital healthcare solutions. The partnership aims to provide caregivers with timely prescriptions for Owlet's FDA-cleared infant pulse oximeter, BabySat, to monitor infant health effectively. The collaboration enhances access to innovative medical-grade monitoring, streamlining the process for caregivers to obtain BabySat through insurance reimbursement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary
Owlet, Inc. reported strong financial results for Q4 2023 and FY 2023, with revenue of $21.0 million and $54.0 million, respectively. The company's net loss decreased significantly by 65% in Q4 and 59% for FY 2023. Owlet's adjusted EBITDA loss also improved by 95% in Q4 and 76% for FY 2023, showcasing operational efficiency and cost reduction efforts. The company's gross margin increased to 47.1% in Q4 and 41.8% for FY 2023, indicating positive financial performance and growth. Owlet's CEO highlighted the successful commercialization of new medical devices, expansion into healthcare channels, and partnerships for reimbursement, setting a strong foundation for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.97%
Tags
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) announces a private placement of Series B preferred stock and warrants to raise $9 million after recent FDA clearances and strong Q4 results. The transaction offers a 25% premium to the market closing price. The company plans to issue 1.2 million common stock shares and warrants to investors, supporting its momentum in infant monitoring devices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.81%
Tags
none
-
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) reports strong financial performance in Q4 2023 with Gross Sales of $32.9 million (up 114% YoY), Net Revenue of $21.0 million (up 75% YoY), Gross Margin at 47% (up over 1,900 bps YoY), Net Loss of $6.9 million (down 65% YoY), and adjusted EBITDA loss of $0.7 million (down 95% YoY). The company attributes the positive results to FDA clearances, cost reduction, and operational improvements. Despite non-recurring items impacting gross margin and EBITDA loss, Owlet anticipates continued growth in 2024 through new product commercialization and expanded distribution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.57%
Tags
conferences earnings
-
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) will participate in the 44th Annual Cowen Health Care Conference. Kurt Workman and Kate Scolnick will engage in a fireside chat on March 5, 2024, at 2:50 p.m. Eastern Time. Investors can access the live webcast on Owlet's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.57%
Tags
conferences
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) announces the launch of Dream Sock and BabySat, two FDA-cleared medical devices for at-home infant monitoring. The devices provide real-time health insights with medical-grade accuracy and aim to help parents monitor their baby's well-being. Dream Sock is a pulse oximetry solution for infants without the need for a prescription, while BabySat is intended for infants with acute or chronic medical conditions. Both devices offer caregivers the ability to track vital signs and receive real-time notifications for low pulse rate and low oxygen levels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.21%
Tags
none
Owlet Inc

NYSE:OWLT

OWLT Rankings

OWLT Stock Data

53.68M
14.86M
8.08%
49.59%
2.29%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States
LEHI